Back to search

Article

Hepatic aldose reductase drives a Warburg effect-like metabolic reprogramming to promote insulin resistance, fatty liver and obesity

2024-09-23

Abstract excerpt

<h4>Background & Aims</h4> Emerging evidence suggest that abnormal activation of aldose reductase/the polyol pathway (Ar/PP) is associated with the pathogenesis or development of fatty liver, obesity and metabolic syndrome. However, the underlying mechanisms were unclear. In this study, we investigated the metabolic reprogramming following activation or inhibition of Ar, the first and the rate-limiting enzyme of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2093cac2-06b8-5216-a0ec-b5c5a2a1ad75
DOI
10.1101/2024.09.23.614395
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hepatic aldose reductase drives a Warburg effect-like metabolic reprogramming to promote insulin resistance, fatty liver and obesityDOI 10.1101/2024.09.23.614395
Select a neighboring publication to make it the new centre.